Miami Dermatology and Laser Research
Miami, Florida, United States
Dermatologist in Sunset, Florida
7800 SW 87th Ave Suite B-200, Miami, FL 33173
About Miami Dermatology and Laser Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
10
Cytrellis Biosystems, Inc.
4
Sebacia, Inc.
3
Pfizer
2
Avita Medical
1
Blackwell Device Consulting
1
Candela Corporation
1
Cutera Inc.
1
Dominion Aesthetic Technologies, Inc.
1
Galderma R&D
1
Horizon Therapeutics Ireland DAC
1
Clinical Trials at Miami Dermatology and Laser Research
During the past decade, Miami Dermatology and Laser Research conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 9 clinical trials were completed, i.e. on
average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris
2014-09-01
2015-12-01
Completed
394
Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea
2014-09-01
2015-08-01
Completed
22
Condition of Submental Fullness and Treatment Outcomes Registry
2015-05-11
2016-11-10
Completed
1,029
Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris
2017-09-25
2018-04-10
Completed
168
CONFORM: Rotational Fractional Resection for Submental Contouring
2018-01-08
2019-04-23
Completed
68
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
2018-02-20
2021-08-16
Completed
440
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
2018-06-27
2022-06-13
Terminated
374
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Miami Dermatology and Laser Research" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Cytrellis Biosystems, Inc." with 4 trials
sponsored, "Sebacia, Inc." with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "Avita Medical"
with 2 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Miami Dermatology and Laser Research"
#1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator, "Alira Health" with 1 trials as a collaborator and "Emblation Limited" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Miami Dermatology and Laser Research
According to Clinical.Site data, the most researched conditions in "Miami Dermatology and Laser Research" are
"Atopic Dermatitis" (6 trials), "Acne Vulgaris" (2 trials), "Dermatitis, Atopic" (2 trials), "Laxity; Skin" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Miami Dermatology and Laser Research" in a lesser frequency.
Clinical Trials Intervention Types at Miami Dermatology and Laser Research
Most popular intervention types in "Miami Dermatology and Laser Research" are "Device" (14 trials), "Drug" (14 trials), "Biological" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Lebrikizumab" (3 trials), "MCD" (3 trials), "Abrocitinib 200 mg" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Miami Dermatology and Laser Research
The vast majority of trials in "Miami Dermatology and Laser Research" are
29 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Miami Dermatology and Laser Research
Currently, there are NaN active trials in "Miami Dermatology and Laser Research".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Miami Dermatology and Laser Research,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Miami Dermatology and Laser Research, 3 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 14 trials that are defined as “Not Applicable".